QUALITY OF LIFE OF ASYMPTOMATIC MEN WITH NONMETASTATIC PROSTATE CANCER ON ANDROGEN DEPRIVATION THERAPY
The DOI matches its Crossref record; 15 of the 16 references it cites were found in a registry or an index.
Abstract
PURPOSE: We evaluate the quality of life of asymptomatic men with nonmetastatic prostate cancer who receive androgen deprivation therapy. MATERIALS AND METHODS: Quality of life was longitudinally evaluated in a cohort of 144 men with locally advanced prostate cancer or prostate specific antigen relapse after local therapy who chose to receive (79 patients) or not to receive (65 patients) androgen deprivation therapy. Androgen deprivation therapy consisted of orchiectomy, leuprolide alone or leuprolide plus flutamide. Multivariate analysis of variance was used to test the effect of different treatment regimens on patient quality of life. RESULTS: Men who received androgen suppression had more fatigue, loss of energy, emotional distress and a lower overall quality of life than men who deferred hormone therapy. Combined androgen blockade had a greater adverse effect on quality of life than monotherapy. CONCLUSIONS: Androgen deprivation therapy may significantly impair the physical and emotional health of asymptomatic patients with nonmetastatic prostate cancer.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These side effects include: hot flashes, osteoporosis, anemia, fatigue, sarcopenia, gynecomastia, loss of libido, erectile dysfunction, risk of diabetes, risk of cardiovascular disease and fatal cardiac events as well as possible emotional distress [9–13].”
From Prostate cancer: Psychosocial implications and management (2008) · cites this paper as [10]
Citations
Cites
Quality-of-life outcomes in men treated for localized prostate cancer
Litwin, M. S., Hays, R. D., Fink, A., Ganz, P. A., Leake, B., Leach, G. E., & Brook, R. H. (1995) · JAMA · doi:10.1001/jama.1995.03520260051032 · Cited by 1,020
Stamey, T. A., Freiha, F. S., McNeal, J. E., Redwine, E. A., Whittemore, A. S., & Schmid, H.-P. (1993) · Cancer · doi:10.1002/1097-0142(19930201)71:3+<933::aid-cncr2820711408>3.0.co;2-l · Cited by 799
Self-citation(1997) · British Journal of Urology · doi:10.1046/j.1464-410x.1997.d01-6840.x · Cited by 654
Adib, R., Anderson, J., Ashken, M. H., Baumber, C. D., CRA, B. D., BEYNON, L. L., Blaxland, J. W., Boag, V., Bolger, J., Boreham, J., et al. (1997) · Kent Academic Repository (University of Kent) · Cited by 551
Viau, V, & Meaney, M. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-05-01866.1996 · Cited by 347
Dalesio, O., VANTINTEREN, H., Denis, L., Schröder, F. H., Blumenstein, B. A., Godwin, J., & Peto, R. (1995) · The Lancet · Cited by 229
Possible role ofHelicobacter pylori infection in early gastric cancer development
Asaka, M., Kimura, T., Kato, M., Kudo, M., Miki, K., Ogoshi, K., Kato, T., Tatsuta, M., & Graham, D. Y. (1994) · Cancer · doi:10.1002/1097-0142(19940601)73:11<2691::aid-cncr2820731107>3.0.co;2-2 · Cited by 213
Self-citationMoore, M. J., Osoba, D., Murphy, K., Tannock, I. F., Armitage, A., Findlay, B., Coppin, C., Neville, A., Venner, P., & Wilson, J. (1994) · Journal of Clinical Oncology · doi:10.1200/jco.1994.12.4.689 · Cited by 160
Quality of Life in Advanced Prostate Cancer: Results of a Randomized Therapeutic Trial
Moinpour, C. M., Lovato, L. C., Yee, M., Blumenstein, B. A., Savage, M. J., Troxel, A., Eisenberger, M., Veith, R. W., Higgins, B., Skeel, R., et al. (1998) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/90.20.1537 · Cited by 148
Research works printed but not linked: 2
- Kornblith, 1994, Quality of life of patients with prostate cancer and their spouses. The value of a data base in clinical care, Cancer, 73, 2791, 10.1002/1097-0142(19940601)73:11<2791::AID-CNCR2820731123>3.0.CO;2-9 · DOI · Paper page
- Herr, 1993, A comparison of the quality of life of patients with metastatic prostate cancer who received or did not receive hormonal therapy, Cancer, 71, 1143, 10.1002/1097-0142(19930201)71:3+<1143::AID-CNCR2820711437>3.0.CO;2-I · DOI · Paper page
Cited by
Androgen Deprivation Therapy for Prostate Cancer
Sharifi, N. (2005) · JAMA · doi:10.1001/jama.294.2.238 · Cited by 1,083
“A quality-of-life study of 144 men given a choice of immediate or deferred ADT found significantly worse scores for fatigue and psychological distress for the men receiving ADT.(56) Men with prostate cancer surveyed at Massachusetts General Hospital were found to have 8 times the national rate of depression.”
BackgroundHeidenreich, A., Bellmunt, J., Bolla, M., Joniau, S., Matveev, V. B., Mottet, N., Wiegel, T., & Zattoni, F. (2013) · Cited by 875
Changes in body composition during androgen deprivation therapy for prostate cancer
Smith, M. R., Finkelstein, J. S., McGovern, F. J., Zietman, A. L., Fallon, M. A., Schoenfeld, D. A., & Kantoff, P. W. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.2.8299 · Cited by 697
Bill-Axelson, A., Holmberg, L., Filen, F., Ruutu, M., Garmo, H., Busch, C., Nordling, S., Haggman, M., Andersson, S.-O., Bratell, S., et al. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn255 · Cited by 603
Sexuality in Adult Cancer Survivors: Challenges and Intervention
Bober, S. L., & Varela, V. S. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.41.7915 · Cited by 448
Metadata
- Authors
- HERR, H. W., & O’SULLIVAN, M.
- Affiliations
- Memorial Sloan Kettering Cancer Center (US)
- Venue
- Journal of Urology
- Published
- 2000-06
- Volume
- 163
- Issue
- 6
- Pages
- 1743-1746
- ISSN
- 0022-5347 (ISSN-L)
- 1527-3792
- OpenAlex
- W2066899660
- Cited by
- 250
- References
- 16
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 1 · 2023: 4 · 2022: 6 · 2021: 1 · 2020: 2 · 2019: 8 · 2018: 8 · 2017: 8 · 2016: 10 · 2015: 12 · 2014: 5 · 2013: 16 · 2012: 12
- FWCI
- 11.36
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- The Journal of Urology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Prostate Cancer Treatment and Research
- Health Sciences › Medicine › Urology › Prostate Cancer Diagnosis and Treatment
- Health Sciences › Medicine › Oncology › Cancer survivorship and care
- Keywords
- quality of life, non-metastatic prostate cancer, androgen deprivation therapy, combined androgen blockade, leuprolide, flutamide, orchiectomy, asymptomatic patients, fatigue, emotional distress, locally advanced prostate cancer, prostate-specific antigen relapse
- MeSH terms
- Aged, Androgen Antagonists, Drug Therapy, Combination, Flutamide, Health Status Indicators, Humans, Male, Middle Aged, Orchiectomy, Prostatic Neoplasms, Quality of Life, Stress, Psychological, Leuprolide, Antineoplastic Agents, Hormonal
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: QUALITY OF LIFE OF ASYMPTOMATIC MEN WITH NONMETASTATIC PROSTATE CANCER ON ANDROGEN DEPRIVATION THERAPY. https://app.cochat.ai/papers/10.1016/s0022-5347(05)67533-7
- The paper
- HERR, H. W., & O’SULLIVAN, M. (2000). QUALITY OF LIFE OF ASYMPTOMATIC MEN WITH NONMETASTATIC PROSTATE CANCER ON ANDROGEN DEPRIVATION THERAPY. Journal of Urology. https://doi.org/10.1016/s0022-5347(05)67533-7
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.